Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril

[1]  J. J. Gerbrands,et al.  Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. , 1985, Circulation.

[2]  B Meier,et al.  Restenosis after successful coronary angioplasty in patients with single-vessel disease. , 1986, Circulation.

[3]  R. Arora,et al.  Restenosis after transluminal coronary angioplasty: a risk factor analysis. , 1990, Catheterization and cardiovascular diagnosis.

[4]  M. Daemen,et al.  Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. , 1991, Circulation research.

[5]  P. Serruys,et al.  Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty With Thromboxane A2‐Receptor Blockade: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 1991, Circulation.

[6]  P W Serruys,et al.  Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. , 1988, Circulation.

[7]  D. Faxon,et al.  Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials. , 1993, Coronary artery disease.

[8]  J. Douglas,et al.  Influence of intimal dissection on restenosis after successful coronary angioplasty. , 1985, Circulation.

[9]  V. Fuster,et al.  Restenosis after arterial angioplasty: a hemorrheologic response to injury. , 1987, The American journal of cardiology.

[10]  M. Nobuyoshi,et al.  Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. , 1988, Journal of the American College of Cardiology.

[11]  J. Tijssen,et al.  Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group. , 1993, Circulation.

[12]  J. Tijssen,et al.  Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and R , 1993, Journal of cardiovascular pharmacology.

[13]  P. Serruys,et al.  Restenosis revisited: insights provided by quantitative coronary angiography. , 1993, American heart journal.

[14]  Galan Km,et al.  Recurrence of stenoses after coronary angioplasty. , 1986 .

[15]  P. Serruys,et al.  Restenosis after coronary angioplasty: new standards for clinical studies. , 1990, Journal of the American College of Cardiology.

[16]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.

[17]  C. Jackson.  Animal models of restenosis. , 1994, Trends in cardiovascular medicine.

[18]  P. Serruys,et al.  Patient, lesion, and procedural variables as risk factors for luminal re- narrowing after successful coronary angioplasty: A quantitative analysis in 653 patients with 778 lesions , 1993 .

[19]  D. Baim,et al.  Defining coronary restenosis. Newer clinical and angiographic paradigms. , 1993, Circulation.

[20]  E. Fleck,et al.  Restenosis after balloon dilatation of coronary stenosis, multivariate analysis of potential risk factors. , 1988, European heart journal.

[21]  S. Ellis,et al.  Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty. , 1989, The American journal of cardiology.

[22]  Charles L. Brown,et al.  Can restenosis after coronary angioplasty be predicted from clinical variables? , 1993, Journal of the American College of Cardiology.

[23]  Melvin L. Marcus,et al.  Cardiac Imaging: A Companion to Braunwald's Heart Disease , 1991 .

[24]  M. Savage,et al.  Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosis☆ , 1991 .

[25]  S. Kelsey,et al.  Percutaneous Transluminal Coronary Angioplasty: Report of Complications from the National Heart, Lung, and Blood Institute PTCA Registry , 1983, Circulation.

[26]  P. Serruys,et al.  Coronary angioplasty for unstable angina: immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome. , 1988, Journal of the American College of Cardiology.

[27]  H. Baumgartner,et al.  Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. , 1989, Science.

[28]  G. Mancini,et al.  Quantitative coronary angiography , 1994 .

[29]  P. Serruys,et al.  Restenosis after coronary angioplasty: the paradox of increased lumen diameter and restenosis. , 1992, Journal of the American College of Cardiology.

[30]  B. Lewis,et al.  Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris. , 1989, The American journal of cardiology.

[31]  H. Stolberg.  Cardiac Imaging: A Companion to Braunwald's Heart Disease , 1991 .

[32]  Lippincott Williams Wilkins,et al.  Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angiopla , 1992, Circulation.

[33]  D. Faxon,et al.  Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. , 1988, The New England journal of medicine.

[34]  D. Baim,et al.  Novel approach to the analysis of restenosis after the use of three new coronary devices. , 1992, Journal of the American College of Cardiology.

[35]  P. Serruys,et al.  Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1,445 successfully dilated lesions. , 1992, Journal of the American College of Cardiology.

[36]  F. Kazim,et al.  Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[37]  S. Goldberg,et al.  Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty--a report from the M-HEART Group. , 1990, The American journal of cardiology.